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Gingipain cysteine proteases are considered key virulence factors of Porphyromonas
gingivalis. They significantly influence antibacterial and homeostatic functions of
macrophages, neutrophils, the complement system, and cytokine networks. Recent
data indicate the role of P. gingivalis in T cell differentiation; however, the involvement
of gingipains in this process remains elusive. Therefore, the aim of this study was
to investigate the contribution of danger signals triggered by the gingipains on the
generation of Th17 cells, which play a key role in protection against bacterial diseases
but may cause chronic inflammation and bone resorption. To this end we compared
the effects of the wild-type strain of P. gingivalis (W83) with its isogenic mutant devoid
of gingipain activity (1K1RAB), and bacterial cells pretreated with a highly-specific
inhibitor of gingipains activity (KYTs). Antigen presenting cells (APCs), both professional
(dendritic cells), and non-professional (gingival keratinocytes), exposed to viable bacteria
expressed high amounts of cytokines (IL-6, IL-21, IL-23). These cytokines are reported
to either stimulate or balance the Th17-dependent immune response. Surprisingly, cells
infected with P. gingivalis devoid of gingipain activity showed increased levels of all tested
cytokines compared to bacteria with fully active enzymes. The effect was dependent
on both the reduction of cytokine proteolysis and the lack of cross-talk with other
bacterial virulence factors, including LPS and fimbriae that induce de novo synthesis of
cytokines. The profile of lymphocyte T differentiation from naive T cells showed enhanced
generation of Th17 in response to bacteria with inactive gingipains. Moreover, we found
that gingipain-dependent induction of Th17 cells was highly specific, since other T
cell-subsets remained unchanged. Finally, inhibition of IL-6 signaling in dendritic cells
led to a significant depletion of the Th17 population. Cumulatively, this study revealed
a previously undisclosed role of gingipain activity in the process of Th17 differentiation
reliant on blocking signaling through IL-6. Since inactivation of gingipains accelerates the
skewing of T cells toward Th17 cells, which are detrimental in periodontitis, IL-6 signaling
may serve as an attractive target for treatment of the disease.
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INTRODUCTION
Periodontitis is a chronic inflammatory disease affecting tissues
surrounding and supporting the teeth, called the periodontium.
The disease is initiated by pathogenic bacteria proliferating
in a biofilm below the gum line, which stimulate a local
inflammatory reaction. Deregulation of the immune system
leads to sustained inflammation, tissue destruction, and gradual
degradation of the tooth-supporting alveolar bone (Di Benedetto
et al., 2013). Among over 500 bacterial species that inhabit
the oral cavity, only a handful are associated with periodontitis
and can be defined as periodontal pathogens. These include
Porphyromonas gingivalis (Socransky et al., 1998), which together
with Treponema denticola and Tannerella forsythia form “the
red complex” that is strongly implicated in the initiation
and progression of chronic periodontitis (Holt and Ebersole,
2005). P. gingivalis expresses a variety of virulence factors,
including fimbriae, lipopolysaccharide, and cysteine proteases—
gingipains. The latter are considered major contributors to
the pathogenic potential of P. gingivalis (Guo et al., 2010).
Moreover, gingipains have been identified in all clinical isolates,
and their expression level correlates with exacerbation of
the disease. Gingipains strongly influence components of the
innate and adaptive immune system (Ismail et al., 2015).
For example gingipains contribute to hyporesponsiveness of
macrophages during infection, reducing the expression of CD14
molecules and diminishing bacterial recognition (Wilensky
et al., 2015). Moreover, gingipains’ proteolytic activity-dependent
modification of the neutrophil surface leads to impaired
clearance of these cells once they become apoptotic (Guzik et al.,
2007). Together, such effects on phagocytic cells augment the
inflammatory reaction in the periodontium, which is further
enhanced by de-regulation of complement system activation
and function (Popadiak et al., 2007; Potempa et al., 2009), and
modification of activity of some cytokines, such as IL-8, INF-γ,
TNF-α, IL-1, CXCL8, andCXCL10 (Yun et al., 2001; Uehara et al.,
2008; Moelants et al., 2014). Finally, gingipains also affect the
adaptive immune system as exemplified by modulation of T cell
function due to hydrolysis of CD4 and CD8molecules (Kitamura
et al., 2002) and efficient cleavage of antibodies (Vincents et al.,
2011).
The chronic inflammatory reaction observed in periodontitis
patients is supported by the altered activation of T lymphocytes,
thus influencing the production of antibodies by B cells.
CD4+ Th cells are major regulators of the adaptive immune
system. They can differentiate into a variety of effector T
cell subsets, such as Th1, Th2, and Th17. Their phenotype
depends on the presence of stimulatory ligands and the
cytokine milieu. A critical role for IL-17 and Th17 cells
in some pathologies is illustrated in autoimmune diseases
such as psoriasis, psoriatic arthritis, or rheumatoid arthritis
(Tesmer et al., 2008). Furthermore, an increasing body of
evidence indicates that Th17 lymphocytes can efficiently promote
osteoclastogenesis and bone resorption in periodontitis (Gaffen
and Hajishengallis, 2008; Okamoto and Takayanagi, 2011;
Moutsopoulos et al., 2012). The major cytokine secreted by Th17
cells is IL-17, which influences both immune and non-immune
cells. This consequently activates proinflammatory signaling
pathways, along with the production of cytokines, chemokines
and matrix metalloproteinases (Witowski et al., 2004; Kramer
and Gaffen, 2007). Moreover, an interaction of IL-17 and Del-1
plays an important role in the recruitment of neutrophils, that
contributes to bone destruction (Eskan et al., 2012). Together
these findings expand the classical framework of the Th1/Th2
paradigm in describing the pathogenesis of periodontitis (Gaffen
and Hajishengallis, 2008).
The differentiation of human naive CD4+ T cells into the
population of Th17 cells is regulated by polarizing cytokines,
such as IL-1, IL-6, IL-21, and IL-23 (Manel et al., 2008). These
cytokines are secreted by antigen-presenting cells in response to
pathogen-associated microbial patterns (PAMPs). Among them,
IL-6 plays a critical role in the differentiation of Th17 cells with
simultaneous inhibition of regulatory T cells (Treg; Kimura and
Kishimoto, 2010). Importantly, IL-6 is also one of the major
target-cytokines for IL-17 signaling, which amplifies the effects
of IL-17 mediated pathology and supports maintenance of Th17
cells by up-regulating expression of IL-23, IL-21, IL-23R, and
RANKL (Scheller et al., 2011). In line with this, several studies in
humans have shown elevated levels of IL-6 and IL-17 in inflamed
gingiva, gingival crevicular fluid and plasma in patients with
periodontitis (Loos, 2005). Due to the crucial role of IL-6 in
skewing lymphocytes toward Th17 phenotype, blocking of IL-6
functionmay become an attractive target for treatment of chronic
inflammatory disease such as periodontitis. Therefore, taking
into account the important role of the gingipains secreted by P.
gingivalis in the pathogenesis of periodontitis, here we studied
their contribution to regulation of the IL-6-Th17 axis.
MATERIALS AND METHODS
Cell Preparation and Cultures
Monocyte-derived dendritic cells (moDCs) were obtained from
PBMCs, which were isolated from human peripheral blood by
using density gradient centrifugation. Monocytes were purified
from the mononuclear cell layer using BD Human Monocyte
Enrichment Set—DM (BD IMag). Cells (2× 106 cells suspended
in 2ml) were cultured in RPMI 1640medium (Life Technologies)
supplemented with 10% FBS (Life Technologies) and 100
U/ml Penicillin-Streptomycin (Life Technologies). moDCs were
generated by adding 10 ng/ml GM-CFS and 500 U/ml IL-4.
Cultures were fed every 2 days by replacing medium with the
fresh supplemented with a full set of cytokines.
Lymphocytes were isolated from the PBMC fraction by using
the BD Human Naive CD4+ T Cell Enrichment Set—DM (BD
IMag) and cultured in RPMI 1640 medium (Life Technologies)
supplemented with 10% FBS (Life Technologies) and 100 U/ml
Penicillin-Streptomycin (Life Technologies). Blood was collected
at the Regional Blood Center, Krakow, Poland, from healthy
donors who provided written informed consent for the collection
of samples and subsequent cell isolation and analysis. For
human subject confidentiality assurances, blood material was de-
identified thus this manuscript adheres to appropriate exclusions
from human subject approval. TIGKs (telomerase-immortalized
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gingival keratinocytes; Moffatt-Jauregui et al., 2013), were
routinely cultured in KBM-Gold TM keratinocyte basal medium
supplemented with Single Quotes TM (Lonza).
Bacterial Growth
P. gingivalis W83, and 1K1RAB were grown under anaerobic
conditions (90% N2, 5%CO2, 5%H2) at 37
◦C on blood (5% v/v
sheep blood) agar plates or in liquid Scheadler broth (BTL, Lodz,
Poland) supplemented with haemin (5 µg/ml; Sigma Aldrich),
L-cysteine (50 µg/ml; Sigma Aldrich), menadione (0.5 µg/ml;
Sigma Aldrich), and in case of 1K1RAB, additionally with
tetracycline (1 µg/ml). Bacteria from an overnight culture were
centrifuged (4500 g, 10min), the bacterial pellet was washed three
times with phosphate-buffered saline (0.14M NaCl, 0.0026M
KCl, 0.01M Na2HPO4, 0.002M KH2PO4), pH 7.4 (PBS), and
resuspended in PBS. Bacterial cell counts were standardized to
an optical density of 1.0 at 600 nm corresponding to 1 × 109
CFU/ml.
Stimulation of moDCS and Keratinocytes
with P. gingivalis
Dendritic cells and keratinocytes (at a concentration of 0.6
× 106/ml) were left untreated (control) or infected with P.
gingivalis W83 or 1K1RAB at multiplicity of infection MOI
1:25, 1:50, 1:100, 1:200 (human cells/P. gingivalis) in the presence
or absence of KYT-1 and KYT-36 (each at 1 µM), specific
inhibitors of gingipains (Peptide Institute Inc.) (Kadowaki et al.,
2004). The inhibitors were added to cultures 15 min before
stimulation of cells. Infected moDCs were cultured for 6 and
24 h, and then used for experiments with T lymphocytes.
Both moDCs and TIGKs infected with P. gingivalis were
cultured for 2, 6, and 24 h, followed by harvesting for RNA
isolation, or collection of culture medium for assay of cytokine
levels.
Gingipain Activity Measurement
After 2, 6, and 24h of stimulation of moDC with P. gingivalis,
a sample of conditioned medium was withdrawn, centrifuged
(12000 × g; 5 min) and 10 µl of supernatant was added
to 90 µl TNCT buffer (50 mM Tris pH 7.5, 150 mM
NaCl, 5 mM CaCl2, 0.05% Tween-20) with 20 mM L-cysteine
followed by 100 µl of 0.2 mM substrate solution. Arginine-
and lysine-specific and gingipain activities were determined
with L-BApNa and N-(p-Tosyl)-Gly-Pro-Lys-4-nitroanilide as
substrates, respectively. Substrate hydrolysis was recorded at
405 nm for 40min and activity expressed as mOD/min/1 µl of
supernatant.
Activation and Inactivation of Gingipain
HRgpA was activated in TNC buffer (50 mMTris, 150 mMNaCl,
5 mM CaCl2, pH 7.5) supplemented with 20 mM L-cysteine
for 15 min in 37◦C. To test the effect of inactivated gingipains,
enzyme samples were treated with specific gingipain inhibitors
KYT-1 and KYT-36 (each at 1 µM) for 15 min in 37◦C before
stimulation of the cells. Cultured media for the cells stimulated
with gingipains contained 10 mM L-cysteine.
Stimulation of moDCS with Virulence
Factors from P. gingivalis
Dendritic cells at a concentration of 0.6 × 106/ml were left
untreated (control) or stimulated with Ultra Pure LPS from P.
gingivalis (InvivoGen) [2.5 µg/ml], FimA purified from ATCC
33277 [10 µg/ml] or both together. Additionally, active or
inhibitor-treated HRgpA [2 nM] was mixed with LPS or FimA
and applied to moDC. Cells were stimulated for 4 h before
culture medium was collected for assay of IL-6 levels and the cells
harvested for RNA isolation.
Quantitative Reverse Transcription PCR
Total cellular RNA was extracted from moDCs, TIGK, and
T cells using TRIzol Reagent, according to the manufacturer’s
instructions. cDNA was prepared by reverse transcription
(RT) using the High-Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). Seven hundred nanograms of RNA
from each sample was used for cDNA synthesis with oligo
(dT) primers, according to the manufacturer’s instructions. The
quantitative PCR (qPCR) reaction was performed with a SYBR
Green method in a reaction volume of 20 µl, containing 0.3
µl (moDC, T cells) or 1 µl (TIGKs) of cDNA sample, 10 µM
of each primer and 1 × SYBR Green JumpStart Taq Ready
Mix. qRT-PCR was performed by using forward and reverse
primers for transcripts of listed genes (Table 1), and for the
housekeeping EF2 gene (used for normalization). After 5 min of
initial denaturation at 95◦C, reactions were carried out for 40
cycles, followed by a final elongation step at 72◦C for 10 min.
Primer sequences and conditions for denaturation (1), annealing
(2), and extension (3) for each pair of primers are provided in
Table 1. Means for threshold cycle (Ct) values were calculated
and analyzed using the “1-1Ct” quantification method (Livak
and Schmittgen, 2001).
Cytokine Assay
The level of IL-6, IFNγ, TNF (BD Bioscience), and IL-23 (Novex
Invitrogen) was determined by using a commercially available
ELISA kit, according to the manufacturer’s instructions. IL-1β,
IL-12p70, IL-8, and IL-10 was determined by using the CBA
Human Inflammatory Cytokine Kit (BD Bioscience) according
to the manufacturer’s instructions and results were analyzed by
FCAP Array v2.0.2.
Proliferation of T Cells
For a proliferation assay, lymphocytes were stained with CSFE
according to the CellTraceTM CFSE Cell Proliferation Kit
Protocol (Molecular Probes). Lymphocytes (at a concentration
of 1.7 × 105/ml) were added to the moDCs cells (0.5 × 105/ml),
which were previously non-infected or infected with P. gingivalis.
Proliferation was evaluated on day 1, 3, 5, and 7 after co-culturing
with moDCs. Data were acquired by the FACSCalibur system
(Becton Dickinson) and analyzed by FlowJo V10 software.
Differentiation of Th Cells
After 3, 5, or 7 days co-culture of moDCs with lymphocytes, T
cells were stimulated with PMA (50 ng/ml) and ionomycin (500
ng/ml) in the presence of Golgi Stop (BD Biosciences),
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TABLE 1 | Oligonucleotide sequences used in the quantitative reverse
transcription polymerase chain reaction (qRT-PCR).
Oligonucleotide Sequence Program
EF2 F 5′-GACATCACCAAGGGTGTGCAG-3′ (1) 95◦C, 30s
(2) 56◦C, 30s
(3) 72◦C, 45s
EF2 R 5′-TTCAGCACACTGGCATAGAGGC-3′
IL-6 F 5′-AAATTCGGTACATCCTCGACGGCA-3′
IL-6 R 5′-AGTGCCTCTTTGCTGCTTTCACAC-3′
IL-21 F 5′-GACTTGGTCCCTGAATTTCTGC-3′
IL-21 R 5′-CCTGCATTTGTGGAAGGTGG-3′
IL-23 F 5′-GCTTTCACAGAAGCTCTGCAC-3′
IL-23 R 5′-AGACCCTGGTGGATCCTTTG-3′
IL-1β F 5′-GATGTCTGGTCCATATGAACTG-3′
IL-1β R 5′-TTGGGATCTACACTCTCCAGC-3′
IL-12p35 F 5′-ATGATGGCCCTGTGCCTTAG-3′
IL-12p35 R 5′-TCCGGTTCTTCAAGGGAGGA-3′
IL-12p40 F 5′-ATTCTGCGTTCAGGTCCAGG-3′
IL-12p40 R 5′-AGAACCTAACTGCAGGGCAC-3′
TNF F 5′-GTCAGATCATCTTCTCGAACCCCGA-3′
TNF R 5′-CAGGGCAATGATCCCAAAGTAGA-3′
IL-6R F 5′-AGCCTCCCAGTGCAAGATTC-3′
IL-6R R 5′-GCATGCTTGTCTTGCCTTCC-3′
IL-1R F 5′-AGGTAGACGCACCCTCTGAA-3′
IL-1R R 5′-GCATTTATCAGCCTCCAGAGAAG-3′
TGFβR F 5′-AGCGGTCTTGCCCATCTTC-3′
TGFβR R 5′-GGGGCCATGTACCTTTTTGTT-3′
RORC F 5′-GACAGGGCCCCACAGAGA-3′
RORC R 5′-GAAGAAGCCCTTGCACCCC-3′
RORα F 5′-AGCCAGGCAGCAGCG-3′
RORα R 5′-AAAAAGCCCTTGCAGCCTCC-3′
STAT3 F 5′-GAAACAGTTGGGACCCCTGA-3′
STAT3 R 5′-AAGCGGCTATACTGCTGGTC-3′
RUNX1 F 5′-GGTTTCGCAGCGTGGTAAAA-3′
RUNX1 R 5′-TGGCATCGTGGACGTCTCTA-3′
IRF4 F 5′-CCATGACAACGCCTTACCCT-3′
IRF4 R 5′-CCTGTCACCTGGCAACCATT-3′
BATF F 5′-CCCTGGCAAACAGGACTCAT-3′
BATF R 5′-GATCTCCTTGCGTAGAGCCG-3′
IFNγ F 5′-GGCTTTTCAGCTCTGCATCG-3′ (1) 95◦C, 30s
(2) 60◦C, 60s
(3) 72◦C, 45s
IFNγ R 5′-TTCTGTCACTCTCCTCTTTCCAA-3′
IL-8 F 5′ -ATGACTTCCAAGCTGGCCGTGGCT-3′
IL-8 R 5′ -TCTCAGCCCTCTTCAAAAACTTCT-3′
and collected for staining. For intracellular staining, a
cytofix/cytoperm kit was used (Becton Dickinson) with
fluorescently labeled antibodies against transcription factors: T-
bet—Alexa Fluor R©488, GATA3- Alexa Fluor R©488, ROR-γt-PE,
Fox-P3-Alexa Fluor R©488, and cytokines: INF-γ-Alexa Fluor R©
647, IL-4-APC, IL-17A-PerCP-Cy5.5. Data were acquired by the
FACSCalibur system (Becton Dickinson) and analyzed by FlowJo
V10 software.
Evaluation of Th17 Signaling Pathway
Molecules Gene Expression
Dendritic cells (0.6 × 106/ml) were stimulated for 6 h with
P. gingivalis strains at MOI 1:50. Lymphocytes (2 × 106/ml)
were added, and after 1, 2, and 3 days of co-culture they
were gently collected, centrifuged (280 × g, 10 min), and
lysed with TRIzol Reagent. RNA was isolated and the relative
expression of genes IL-6R, IL-1R, TGFβ , RORc, RORα, STAT3,
RUNX1, IRF4, BAFT to the reference house-keeping gene
EF2 was measured by using the qRT-PCR method described
above.
Evaluation of STAT3 and IRF4 Activation
Three, 4 and 5 days after co-culture of moDCs with lymphocytes,
T cells were stimulated with PMA (50 ng/ml) and ionomycin
(500 ng/ml) in the presence of Golgi Stop (BD Biosciences),
and collected for staining. For intracellular staining, a
cytofix/cytoperm kit was used (Becton Dickinson) with
fluorescently labeled antibodies against transcription factors:
Alexa Fluor R©488 Mouse Anti-Stat3 (pY705; BD Biosciences)
and PE-IRF4 Monoclonal Antibody (3E4)(eBioscience). Data
were acquired by the FACSCalibur system (Becton Dickinson)
and analyzed by FlowJo V10 software.
Statistical Analysis
All experiments were performed at least in triplicate, and results
were analyzed for statistical significance using Student’s t-tests or
ANOVA. All values are expressed as means± SD, and differences
were considered significant at p< 0.05.
RESULTS
IL-6 Expression Induced by P. gingivalis
Depends on Activity Status of Gingipains
In response to danger signals expressed by a pathogen,
antigen presenting cells, including dendritic cells (DCs), produce
inflammatory cytokines. Among them, IL-6 plays a critical role in
Th17 differentiation and IL-17 signaling. Since an elevated level
of IL-6 was previously reported in inflamed gingiva (Imamura,
2003), we decided to investigate the extent to which DCs-
specific cytokine pattern depends on expression and/or activity
of gingipains. For that purpose, we used an in vitro model
of primary human dendritic cells differentiated from blood
monocytes (moDCs) as described in the Section Materials and
Methods. Briefly, cells were infected with wild-type (WT) P.
gingivalis W83 expressing gingipains (HRgpA, RgpB, and Kgp)
in the presence or absence of KYTs, specific inhibitors of
gingipains (Kadowaki et al., 2004), at a multiplicity of infection
(MOI) of 1:25, 1:50, 1:100, and 1:200. In parallel, cells were
infected with the gingipain-null isogenic mutant (1K1RAB).
The expression of IL-6 transcript was measured 2 h post
infection (p.i.), whereas the level of secreted IL-6 in conditioned
culture media was measured at 2, 6, and 24 h p.i. In this
experimental setup P. gingivalis was a potent and rapid inducer
of IL-6 mRNA expression (2 h) in a MOI-dependent manner
for all tested strains and conditions. Surprisingly, the most
potent inducers were the gingipain-null strain (1K1RAB) and
bacteria with ablated gingipain activity (W83/KYT; Figure 1).
The level of secreted IL-6 only weakly corresponded to changes
in IL-6 expression observed at the mRNA levels (Figure 2).
P. gingivalis was a potent inducer of IL-6 secretion in a
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FIGURE 1 | Expression of interleukin 6 in human monocyte-derived dendritic cells in response to Porphyromonas gingivalis infection. Monocyte-derived
dendritic cells (moDC) were untreated or exposed to P. gingivalis W83 in the presence or absence of specific protease inhibitors (KYT-1 and KYT-36, each at a
concentration of 1 µM) or the isogenic gingipain-null mutant ∆K∆RAB for 2 h. After stimulation, cells were lysed with TRIzol, RNA was isolated and reverse
transcriptase PCR was performed. Relative expression of IL-6 was measured by using the Real-Time PCR method. A representative qRT-PCR from three separate
experiments performed on moDCs derived from different donors is shown. Data are presented as means ± standard deviations of triplicate assays, and were
analyzed with the one-way ANOVA with the Bonferroni post-test correction (#P < 0.05, ##P < 0.01 vs. control, *P <0.05 to P. gingivalis treated cells).
MOI- and time-dependent manner (Figures 2A–C) but only if
gingipain activity was entirely absent (1K1RAB, Figures 2D–I).
In cultures infected with WT P. gingivalis at a MOI range
from 1:25 to 1:200 we found no accumulation of IL-6 in
the conditioned medium (Figures 2A–C) apparently due to
gingipain activity, which degrades the cytokine (Figures 2D–I).
This contention was confirmed by observation of the transient
increase of the IL-6 level at 6 h p.i. in cells infected in the
presence of KYTs (Figure 2B). At 24 h p.i., however, together
with the increase of gingipains’ activity (Figures 2D–I), the
concentration of IL-6 in the medium dropped to the level
detected in non-infected control cells (Figures 2A–C). Taken
together, accumulation of IL-6 in conditioned medium of cells
infected with P. gingivalis was inversely dependent on the
presence of active gingipains. Consistent with this, deletion of
all three genes encoding gingipains notably up-regulated the
IL-6 transcript, when compared to the parental strain with
fully active enzymes. To further analyze the mechanism of our
observation we estimated the role of both active and inactive
enzymes on moDCs activation induced by other P. gingivalis
virulence factors, such as: LPS and fimbriae. The analysis of IL-6
expression at mRNA and protein levels revealed that synthesis of
the cytokine upon stimulation with each cell wall component was
strongly inhibited by active gingipains. This indicates that active
gingipains interfere with an upstream pathway of stimulation
of IL-6 expression (Figures 3A,B). The effect was abrogated
when inactive enzymes were used. Cumulatively, the data not
only confirm proteolytic degradation of the cytokine (Banbula
et al., 1999), but also supports a contribution of gingipains
to modulation of immune responses to otherwise stimulatory
P. gingivalis antigens. Moreover, the results indicate that IL-6
production strongly depends on both gingipain expression and
activity.
The Profile of Cytokine Expression That
Promotes Th17 Differentiation Depends on
Gingipains
It is suggested that the high level of IL-6 documented in the
inflamed periodontal tissue contributes to deregulation of the
immune system, which then promotes tissue destruction and
disease progression. The detrimental effect of IL-6 can be partly
explained by the induction of naive T cell differentiation toward
the Th17 phenotype. Since we found that IL-6 upregulation is
inversely dependent on activity of gingipains, we decided to
estimate the level of other cytokines (IL-23 and IL-1β) known
for their regulatory effect on the differentiation of Th17 cells.
Infection of moDCs with P. gingivalis stimulated secretion
of IL-23 and increased accumulation of this cytokine in the
conditioned medium but only in the presence of bacteria devoid
of gingipain activity (Figure 4A). In the case of IL-1βwe observed
a similar trend, however the amount of the protein was close
to the limit of detection (Figure 4A). Since P. gingivalis was
described as a pathogen that promotes skewing of T cells into
Th1 phenotype (Stashenko et al., 2007; Zeituni et al., 2009), we
estimated the level of cytokines critical for that process. The
analysis of IL-12 and IFNγ revealed no accumulation of either
cytokine in conditioned media (Figure 4A). Further, extended
analysis of other pro- and anti- inflammatory cytokines showed
upregulation of IL-10, IL-8, and TNFα in moDCs infected with
P. gingivalis. Interestingly, the levels of IL-8 and IL-10 were
inversely dependent on activity of gingipains as we observed
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FIGURE 2 | Interleukin 6 production induced by P. gingivalis is inversely dependent on gingipain activity. Monocyte-derived dendritic cells (moDC) were
untreated or exposed to P. gingivalis W83 in the presence or absence of specific protease inhibitors (KYT-1 and KYT-36, each at 1 µM concentration) or isogenic
P. gingivalis gingipain-null mutant 1K1RAB for 2 h (A,D,G), 6 h (B,E,H), and 24 h (C,F,I). (A–C) Supernatants were collected and the concentration of IL-6 was
determined by ELISA. (D–F) Arginine-specific and (G–I) Lysine-specific gingipain activity was determined using L-BApNa and N-(p-Tosyl)-Gly-Pro-Lys-4-nitroanilide
acetate salt (200 µM) as a substrate, respectively. Data are presented as means ± standard deviations of assays performed in triplicate using three independent
donors, and were analyzed by one-way ANOVA with the Bonferroni post-test correction (#P < 0.05, ##P < 0.01, ###P < 0.001 vs. control, *P < 0.05, **P <
0.01, ***P < 0.001 to P. gingivalis treated cells).
for IL-6. Transcriptome analysis revealed an increase in mRNA
of all tested cytokines, however only in case of IL-6, INFγ,
IL-8, and TNFα was the expression reversely correlated with
the activity of gingipains (Figure 4B). The expression of IL-6
was also verified in non-professional antigen presenting cells,
human immortalized gingival keratinocytes (TIGKs). Infection
of these cells with viable bacteria induced the strong upregulation
of the IL-6 transcript (Supplementary Figure 1) that inversely
correlated with gingipain activity. Of note, we observed no
influence of KYT inhibitors at the applied concentration on cell
morphology, viability, proliferation, differentiation, and cytokine
expression (data not shown). Taken together, these data indicate
that inhibition of gingipains during periodontitis may strongly
enhance the secretion of a set of cytokines required for Th17
differentiation in tissues infected with P. gingivalis.
The Differentiation of T Cells into Th17
Phenotype Is Regulated by Gingipains
Based on the finding that gingipains play an important role in
the regulation of cytokine expression that promotes induction
and/or maintenance of Th17 population, we investigated the
potential of these enzymes to influence the proliferation and
differentiation of other CD4+ T helper effector cells. To this
end, we determined the potential of gingipains to drive T cell
proliferation and shift into other Th phenotypes. We infected
moDC with WT P. gingivalis in the absence and the presence
of KYTs to inactivate gingipains. Cells were also infected with
the gingipain-null isogenic mutant (1K1RAB). Naive CD4+ T
cells were labeled with CSFE and cultured with moDCs 6 h post
P. gingivalis infection. The proliferation of CD4+ T cells was
significantly induced after 1 day of lymphocyte co-culture with
moDCs, when compared to the control population of CD4+ T
cells, and an increased division rate of cells was sustained up to
day 5 (Figures 5A,B). There was no difference in proliferation
between cells exposed to moDCs infected with WT P. gingivalis
or the inhibitor-treated bacteria, whereas the rate of CD4+T cells
proliferation exposed to moDCs infected with the gingipain-null
isogenic mutant was significantly reduced, when compared to the
WT strain (Figure 5A).
Next, we analyzed co-culture of T cells with P. gingivalis
infected moDCs for CD4+ T cell differentiation at day 3 and
5. At day 3 only slight changes in the profile of the CD4+
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FIGURE 3 | The role of gingipains in the regulation of cell responses to
LPS and fimbriae. Monocyte-derived dendritic cells (moDC) were untreated
or exposed to P. gingivalis LPS (2.5 µg/ml), FimA (10 µg/ml) or mixed LPS with
FimA. Additionally, cells were co-stimulated with HRgpA (2 nM) in the presence
or absence of specific protease inhibitors (KYT-1 and KYT-36, each at a
concentration of 1 µM). Four hours after stimulation, culture media were
collected and cells were lysed with TRIzol. RNA was isolated and reverse
transcriptase PCR was performed. Relative expression of the cytokine gene
IL-6 to the reference house-keeping gene EF2 was measured by Real-Time
PCR. Data show representative fold increase in expression compared to
control levels, which were arbitrarily set at 1 (A). Concentration of IL-6 in
collected medium was evaluated by standard ELISA method (B); Data are
presented as mean ± standard deviation of duplicates from three independent
assays and were analyzed with a Student’s t-test (#P < 0.05, ##P < 0.01,
###P < 0.001 vs. control, *P <0.05, **P < 0.01 to P. gingivalis treated cells).
T cell phenotype were observed when compared to control
cells (Figure 5C). However, at day 5 a potent induction of Th1
and Th17 populations of CD4+ T helper cells was observed
in contrast to the Th2 population, which remained unaffected
(Figure 5C). Notably, the highest polarization toward the Th17
phenotype in the population of CD4+ T cells co-cultured with
moDCs occurred when the cells were infected with P. gingivalis
devoid of gingipain activity (Figure 5C).
Detailed analysis of the Th17 differentiation process revealed
robust induction of the Th17 specific transcription factor RORγt
(Figure 6), which was observed by day 3 following co-culture.
Interestingly, this effect was detected only with bacteria deficient
in gingipain activity. The further increase of RORγt positive cells
was observed 2 days later (day 5) reaching 2- and 3-fold higher
induction levels (over the base line) in the case of infection
with the WT strain or with bacteria deficient in gingipains,
respectively (Figure 6). The expression of IL-17 was detected
at day 5 post co-culture of T-cells with infected moDCs. The
highest level of IL-17 positive cells was observed for infections
with bacteria that were devoid of gingipain activity (Figure 6),
thus corresponding to the activation of the transcription factor.
To expand our studies, we evaluated some of the discrete
events in the Th17 signaling. Firstly, we estimated the expression
of positive regulators of the IL-17 in T cells, including
receptors, adapter molecules, and transcription factors. The
dynamic changes in the expression of particular molecules
were observed between the first to the third day after T
cells were exposed to moDCs infected with P. gingivalis. The
most interesting finding was the initial upregulation of IRF-
4 and BATF (day 1, 2), with subsequent induction of RORc,
RORα and receptor for IL-1β (day 3; Figure 7). The highest
expression was observed in infection with the P. gingivalis
strain devoid of gingipains. Further analysis revealed activation
of STAT3 and IRF-4, two transcription factors that play a
major role in Th17 differentiation (Figures 8A,B). IRF-4 activity
dominated in early post T cells co-culture with infected
moDCs (day 3), whereas STAT-3 activity was delayed and its
maximal effect was detected 2 days later (day 5). In both
cases the activation level negatively correlated with gingipain
activity. Collectively, we documented that the process of Th17
differentiation induced by P. gingivalis is negatively regulated by
active gingipains.
Inhibition of IL-6 Signaling Prevents
Gingipain-Derived Th17 Generation
IL-6 is one of the major and crucial cytokines responsible for
generation of Th17 cells. IL-6 expression leads to cell activation
via JAK kinases, and IL-6 mediated JAK2 phosphorylation
activates STAT3, which stabilizes the transcription factor RORγt
and promotes IL-17 expression. Therefore, we investigated the
impact of IL-6 function on Th17 differentiation by selective
blocking of the IL-6 signaling pathway. Ruxolitinib, an inhibitor
of JAK kinases, was added to moDCs infected with P. gingivalis
just before co-culturing with CD4+ T cells. Analysis for the
Th17 phenotype revealed the ablation of their differentiation
from naïve T lymphocytes, but only in the case of cells cultured
with moDCs infected with the gingipain-null mutant or in
the presence of KYTs (Figure 9A). The role of IL-6 signaling
in gingipain-dependent differentiation of CD4+ T-cells was
confirmed using antibody blocking of the IL-6 receptor that
prevents formation of the IL-6/IL-6R complex (Figure 9B).
Collectively, our data revealed for the first time, that
the process of Th17 differentiation induced by P. gingivalis
is gingipain-dependent and is mediated via IL-6 expression.
Moreover, we documented the role of enzymatically active
gingipains from P. gingivalis in the negative regulation of the
phenotype switch of CD4+ T helper effector cells and Th17
differentiation. Taken together, the inhibition of IL-6 signaling
rather than gingipain activity might be a more appropriate target
of treatment of chronic periodontitis since it leads to restoration
of the low level of Th17 and regulation of its biological activity.
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FIGURE 4 | Gingipain activity differentially determines the mRNA expression and final secretion of cytokines. (A) Monocyte-derived dendritic cells (moDC)
were untreated or exposed to P. gingivalis W83 in the presence or absence of specific protease inhibitors (KYT-1 and KYT-36, each at a concentration of 1 µM) or the
isogenic gingipain-null mutant 1K1RAB at MOI (multiplicity of infection) 1:50. (A) Concentrations of cytokines in collected medium were evaluated by ELISA (IL-6,
IL-23, TNF, IFNγ) or by using BD CBA Human Inflammatory Kit (IL-1β, IL-12p70, IL-8, IL-10). A representative result from three separate experiments performed on
moDCs derived from different donors is shown. Data are presented as mean ± standard deviation of duplicates from three independent assays and were analyzed
with a Student’s t-test (#P < 0.05, ##P < 0.01, ###P < 0.001 vs. control, *P < 0.05, **P < 0.01, ***P < 0.001 to P. gingivalis treated cells). (B) The expression of
mRNA for cytokines was evaluated 2 and 6 h post P. gingivalis infection by RT-PCR. Data are representative result of fold increase in expression compared to control
levels, which were arbitrarily set at 1.
DISCUSSION
Th17 lymphocytes play an important role in the regulation of
the immune response and bone resorption in a number of
chronic diseases, such as rheumatoid arthritis and osteoarthritis
(Wang et al., 2013). Recently, Th17 differentiation was also
identified in periodontitis, the most prevalent form of bone
pathology in humans aﬄicting up to 40% of the population in
developed countries (Eke et al., 2012). Several clinical studies of
chronic periodontitis have shown the presence of Th17 cells in
the inflamed gingiva (Moutsopoulos et al., 2012). Interleukin-
17 (IL-17) is a signature cytokine of Th17 cells. The IL-17
family of cytokines consists of several members such as IL-
17A-F, which has emerged as key component of host defense
responses and inflammatory diseases (Weaver et al., 2007).
Although a substantial amount of data indicate that IL-17 plays
a protective role in host defense against bacterial infections, it is
also clear that excessive activation of the IL-17 pathway mediates
connective tissue destruction and bone resorption (Lubberts,
2008). For instance, elevated levels of IL-17 were reported in
human chronic periodontitis (Gaffen and Hajishengallis, 2008;
Ohyama et al., 2009). Moreover, studies performed using amouse
model of periodontitis have revealed the significance of IL-17
for pathological bone loss (Eskan et al., 2012). It was found that
upon aging, excessive expression of IL-17 led to spontaneous
development of periodontitis, which was not observed in IL-
17R–/– mice. The critical role of IL-17 in mediating bone loss
was confirmed using a ligature model of periodontitis where
local administration of mAbs to IL-17A or IL-17F inhibited bone
destruction (Eskan et al., 2012).
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FIGURE 5 | Proliferation and differentiation of CD4+ T cells mediated by gingipains from P. gingivalis. Monocyte-derived dendritic cells (moDC) were
untreated or exposed to P. gingivalisW83 in the presence/absence of specific protease inhibitors (KYT-1 and KYT-36, each at a concentration of 1 µM) or the isogenic
gingipain-null mutant 1K1RAB for 6 h at MOI (multiplicity of infection) 1:50. Naive CD4+ T cells stained with CFSE were added and co-stimulated for 5 days.
Proliferation of lymphocytes was measured at day 1, 3, and 5. (A) Completed results of proliferation on day 1, 3, and 5 as a percentage of CFSE low cells. Data are
presented as a mean ± standard deviation of assays performed in triplicate using four independent donors, and were analyzed with a two way ANOVA with the
Bonferoni’s posttest correction (#P < 0.05, ###P < 0.001 vs. control, **P < 0.01 to P. gingivalis treated cells) (B) Gating strategy for evaluation of T cell proliferation by
CFSE dilution. All CD4+ cells having a lower CFSE intensity than intact control lymphocytes were treated as proliferating cells. Data represent the proliferation of
lymphocytes on day 5 and show percentage of CFSE low cells. A representative dot plot out of three separate experiments performed on lymphocytes derived from
different donors is shown. (C) After stimulation with bacteria, the naive CD4+ cells were added and co-cultured for an additional 3 or 5 days. At the end of each
period, T cells were stimulated with PMA and ionomycin for 4 h in the presence of GolgiStop. For the evaluation of the Th population, cells were stained for intracellular
IFN-γ, T-bet (Th1), IL-4, GATA-3 (Th2), IL-17A, RORγt (Th17), and analyzed by flow cytometry. Data show fold increase of the transcription factor and the cytokine
positive population, relative to the appropriate control set at 1. Data are presented as a mean ± standard deviation of assays performed in triplicate using cells from
three different donors, and were analyzed with a Student’s t-test (#P < 0.05, ##P < 0.01 vs. control, ###P < 0.001, *P < 0.05 to P. gingivalis treated cells).
Despite the undeniable role of IL-17 in the development of
periodontitis, the molecular mechanism of Th17 differentiation
underlying this phenomenon is not known. It is very likely
that P. gingivalis, the major periodontal pathogen present in
circa 73% of patients suffering from chronic periodontitis,
is involved in Th17-dependent pathology. All characterized
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FIGURE 6 | Th17 cells differentiation depends on gingipain activity. Monocyte-derived dendritic cells were untreated or exposed to P. gingivalis W83 in the
presence/absence of specific protease inhibitors (KYT-1 and KYT-36, each at the concentration of 1 µM) for 6 h. Naive CD4+ cells were added and co-cultured for an
additional 3 or 5 days. At the end of each period, T cells were stimulated with PMA and ionomycin for 4 h in the presence of GolgiStop. For evaluation of the Th17
population, cells were stain for intracellular IL-17A andRORγt, and were analyzed by flow cytometry. Data show a representative dot blot selected from three separate
experiments presenting percent of RORγt+, IL-17+, RORγt+ IL-17+ after 3 and 5 days of co-stimulation of naive CD4+ T cells with moDC pulsed with P. gingivalis.
strains of P. gingivalis, as well as clinical isolates, produce
gingipains (Ismail et al., 2015), which are major virulence
factors capable of manipulation of a large number of defense
and homeostatic mechanisms in infected tissue. Therefore,
these cysteine proteases play a crucial role in progression of
inflammation of the gingiva and tissue destruction (Guo et al.,
2010; Ismail et al., 2015); however, their involvement in the
regulation of Th17 differentiation has not been addressed.
The process of differentiation of naive CD4+ T cells into
a particular subset of lymphocytes is regulated by cytokines
expressed by activated antigen presenting cells (Luckheeram
et al., 2012). Previous studies in humans have shown that
elevated levels of some cytokines, such as IL-1β, IL-6, IL-21,
and IL-23, are necessary for promoting Th17 differentiation
and maintenance during the destructive phase of periodontitis
(Takahashi et al., 2005; Moutsopoulos et al., 2012; Rao et al.,
2015). Additionally, in vitro studies have reported the production
of these Th17 supporting cytokines in cell cultures infected with
P. gingivalis (Moutsopoulos et al., 2012). However, there are
no data clearly showing the contribution of gingipains to this
process. In the current study, we performed a complex analysis
of the expression of Th17 relevant cytokines, both at the mRNA
and protein levels, in cells exposed to P. gingivalis. To examine
the role of gingipains in this process we stimulated professional
(dendritic cells) and non-professional (gingival keratinocytes)
antigen presenting cells with vital P. gingivalis in the presence or
absence of specific inhibitors of gingipains (KYTs), as well as with
an isogenic gingipain-null mutant entirely devoid of cysteine
proteases (1K1RAB). Surprisingly, we found that the inhibition
of gingipain activity and deletion of all of the gingipain genes
led to a significant increase of transcripts encoding IL-6, IL-21,
and IL-23, which are crucial for Th17 polarization. The high
levels of the IL-6 transcript correlated with the accumulation
of the mature cytokines in conditioned medium but only in
cultures infected with P. gingivalis depleted of gingipain activity
by inhibitor treatment or genetic manipulation. Similar results
were obtained with IL-8 and TNFα. These findings corroborate
previous observations showing that heat-killed bacteria elicited
production of a number of cytokines (Stathopoulou et al.,
2009; Palm et al., 2013). Clearly, the proteolytically active
gingipains strongly diminished the expression of cytokines at
the transcriptional level. This down-regulatory effect of active
gingipains on cytokine expression can be explained by their
newly discovered ability to selectively proteolytically inactivate
RIPK1, TAK1, and AKT kinases, which consequently impairs the
immune response (Barth andGenco, 2016).Moreover, gingipains
are known for their direct ability to degrade cytokines as IL-1β,
IL-12, IL-6, and IL-8 (Banbula et al., 1999; Stathopoulou et al.,
2009; Moutsopoulos et al., 2012), thus the lower level of the tested
cytokines in the conditioned medium of cultures infected with
untreated WT P. gingivalis can be explained by this mechanism.
In fact, our data confirm that proteolytic activity of gingipains
results in degradation of IL-6 (Banbula et al., 1999), which
was clearly demonstrated using a reversible inhibitor of their
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FIGURE 7 | Activation of Th17 signaling pathway in CD4+ naïve lymphocyte depends on gingipain activity. Monocyte-derived dendritic cells (moDC) were
untreated or exposed to P. gingivalis in the presence or absence of specific protease inhibitors (KYT-1 and KYT-36, each at a concentration of 1 µM). After 6 h, CD4+
naïve lymphocytes were added and co-stimulated for 3 consecutive days. At day 1, 2, and 3 after co-incubation, cells were collected and lysed with TRIzol, RNA was
isolated and reverse transcriptase PCR was performed. Relative expression of cytokine genes IL-6R, IL-1R, TGFβR, RORc, RORα, STAT3, RUNX1, IRF4, BATF to the
reference house-keeping gene EF2 was measured by Real-Time PCR. Data represent fold increase in expression compared to control levels, which were arbitrarily set
at 1 and were analyzed with a Student’s t-test (#P < 0.05, ##P < 0.01, ###P < 0.001 vs. control, *P < 0.05, **P < 0.01, ***P < 0.001 to P. gingivalis treated
cells).
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FIGURE 8 | Activation of STAT3 and IRF4 is dependent on gingipain activity. At the end of each period, T cells were stimulated with PMA and ionomycin for 4 h
in the presence of GolgiStop. Cells were stained for intracellular (A) IRF4 and (B) pSTAT3 (pY705), and IRF4, and analyzed by flow cytometry. Data show fold increase
of the transcription factor positive population, relative to the appropriate control set at 1. Data are presented as a mean ± standard deviation of triplicate assays and
were analyzed with a Student’s t-test (#P < 0.05, ##P < 0.01, ###P < 0.001 vs. control, *P < 0.05, **P < 0.01, ***P < 0.001 to P. gingivalis treated cells).
activity (KYTs). Collectively, the data revealed that inactivation
of gingipains led to strong upregulation of the Th17 relevant
cytokines by at least a two pronged protease activity-dependent
mechanism: inactivation of regulatory kinases and degradation
of secreted cytokines. In this manner, gingipains strongly down-
regulate the local inflammatory reaction. Conversely, gingipain
inactivation strongly promotes activation of signaling pathways
leading to expression of IL-6, IL-21, and IL-23 and thus the
development of Th17 cells. Together, the results of our studies
argue that the mechanism of Th17 differentiation in the gingiva
should be more carefully studied. Although gingipains are
not inhibited by any of human protease inhibitors, they are
cysteine proteases and thus activity is dependent on a reducing
environment. Therefore, it is conceivable that while diffusing
away from the anoxic environment of periodontal pockets into
oxygenated tissues they become enzymatically inactive due to
oxidation of the thiol group of the catalytic cysteine residue, thus
promoting the Th17 phenotype. The presence of gingipains in
the deep in the gingival tissue (O-Brien-Simpson et al., 2003)
lends support to this hypothesis. The balance of active and
inactive gingipain may thus determine the composition of the
local inflammatory milieu and have a strong influence on the
scale of Th17 differentiation and progression of periodontitis.
In previous studies on the role of P. gingivalis in the
differentiation of Th17, it was found that supernatants collected
from P. gingivalis-infected myeloid APC were capable of
expanding the Th17 population of CD4+ T cells, but not
the Th1 population. Among all tested APCs, dendritic cells
stimulated with P. gingivalis were the most effective in inducing
Th17-differentiation (Moutsopoulos et al., 2012). To extend
our findings, we also used monocyte-derived dendritic cells to
explore the role of gingipains in Th17 differentiation. Moreover,
in a deaparture from previous work (Moutsopoulos et al.,
2012) we co-cultured infected moDC with a purified fraction
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FIGURE 9 | Blocking the IL-6 signaling pathway results in reduction of the Th17 population stimulated by gingipains. Monocyte-derived dendritic cells
were untreated or exposed to P. gingivalis W83 in the presence/absence of specific protease inhibitors (KYT-1 and KYT-36, each at a concentration of 1 µM) for 6 h.
Cultures were treated with the inhibitor of JAK1/JAK2 (Ruxolitinib [1 µM]) (A) or antibodies against the IL-6 receptor [10 µg/ml]) (B) for 2 h then naive CD4+ cells were
added and cells were co-cultured for 5 or 7 days. At the end of each period, T cells were stimulated with PMA and ionomycin for 4 h in the presence of GolgiStop. For
the evaluation of the Th17 population, cells were stained for IL-17A and RORγt, and analyzed by flow cytometry. Data show transcription factor and cytokine positive
cells (RORγt+ IL-17A+) and are presented as a mean ± standard deviation of assays performed using three independent donors. Data were analyzed with a
Student’s t-test (*P < 0.05, **P < 0.01, ***P < 0.001 to P. gingivalis treated cells).
of naive CD4+ T cells. In this system more closely resembling
situation in vivo, we observed that bacterial infection significantly
increased proliferation of lymphocytes. However, the rate of
this process was substantially lower when the gingipain-null
mutant (1K1RAB) was used. In contrast to the previous
observation (Moutsopoulos et al., 2012), we observed the
induction of all tested CD4+ T cells subsets including Th1,
Th2, and Th17. Notably, only the expansion of the Th17 cells
population inversely correlated with the activity of gingipains,
apparently related to the higher production of IL-6 and other
related cytokines in co-cultures infected with the gingipain
devoid bacteria. This is further augmented by the effect of
inactive gingipains on several signaling components promoting
IL-17/Th17 expression. Thus, it can be postulated that in contrast
to inactive forms of gingipains, which are likely present in
tissues distant from the periodontal pocket, enzymatically active
gingipains in the anoxic tissue proximal to subgingival biofilm
do not support maturation and differentiation of naive CD4+
lymphocytes into the Th17 population.
It is well-established that gingipains are primary virulence
factors of P. gingivalis (Potempa et al., 2003) which determine
disease progression in a murine model of alveolar bone loss
(Pathirana et al., 2007; Wilensky et al., 2013). It is postulated
that suppression of gingipain activity may reduce availability of
nutrients and growth factors necessary for bacterial proliferation
(Sroka et al., 2001; Imamura et al., 2003). In addition, it is
generally accepted that inhibition of gingipains would render
P. gingivalis susceptible to clearance by host defenses in the
periodontal tissues (Olsen and Potempa, 2014). Therefore, these
proteases seem to be a perfect target for development of novel
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therapeutics for periodontitis and associated systemic disorders,
including cardiovascular disease, aspiration pneumonia, or pre-
term birth low birth weight delivery (Olsen and Potempa, 2014).
However, in light of our finding presented here it is clear that
blocking the activity of gingipains with specific inhibitors may
result in local up-regulation of immune responses and increased
promotion of Th17 lymphocyte differentiation, which are
associated with bone loss and chronic inflammatory responses.
Importantly, our data evidently showed that IL-6 production was
inversely correlated with the activity of gingipains. The presence
of this cytokine is considered to be a marker of many chronic
and autoimmune diseases such as Castleman disease, asthma, or
multiple sclerosis (Yao et al., 2014). It is also well-defined that IL-6
plays a pivotal role in the bone pathology by its ability to promote
the Th17 differentiation observed in rheumatoid arthritis and
periodontitis (Yao et al., 2014). Together, these findings indicate
caution in treatment of periodontitis by inhibition of gingipains,
as this might have undesirable side effects.
Results of intensive studies on the biological activities of IL-6
and its pathological role imply that abrogation of IL-6 function
and/or blockade of cytokine signaling pathways is a promising
therapeutic strategy in inflammatory and autoimmune diseases
(Yao et al., 2014). Thus, blocking of IL-6 signaling should be
also considered as a potential strategy to treat periodontitis
fueled by the inflammatory reactions propagated by periodontal
pathogens. Indeed, Kobayashi et al. demonstrated recently
that periodontal patients treated with Tocilizumab (TCZ), a
recombinant humanized anti-human IL-6 receptor monoclonal
antibody, displayed decreased inflammation in periodontal tissue
(Kobayashi et al., 2015). This observation is in line with our
finding here that antibodies against the IL-6 receptor significantly
reduced the Th17 population. Moreover, IL-6 signaling activates
the receptor-associated kinases JAK1, JAK2, and TYK2, which
are responsible for the phosphorylation of STAT1 and STAT3.
Activated STATs translocate to the nucleus and regulate the
expression of numerous genes (Xiong et al., 2014). STAT3 is
known as a crucial regulator of anti-apoptotic genes, and plays an
important role in tumor growth, survival, and angiogenesis (Yu
et al., 2009). In the case of the bone pathology, STAT3 is necessary
for differentiation of Th17 cells, and regulates the expression of
RORγt related to this population of lymphocytes. Furthermore,
deficiency in STAT3 results in a decrease in RORγt expression
and leads to increased levels of the T-bet and Foxp3 transcription
factors which are characteristic for Th1 and Treg subpopulations,
respectively (Yang et al., 2007).
Knowing that the JAK/STAT signaling pathway is involved
in the regulation of CD4+ T cells we investigated the role
of blocking JAK1/2 kinases on Th17 development induced
by P. gingivalis. We applied Ruxolitinib, a newly discovered
inhibitor of JAK1/JAK2 previously used in the treatment of
myelofibrosis. Yajnanarayana et al. showed that Ruxolitinib
is a potent inhibitor of Th1, Treg, and Th17 differentiation
(Parampalli Yajnanarayana et al., 2015). In our model, we tested
whether this inhibitor can abolish Th17 differentiation induced
by an elevated level of IL-6 generated in response to P. gingivalis.
Our data demonstrated that Ruxolitinib significantly reduced the
percentage of RORγt and IL-17 positive cells, and thus IL-6might
be taken into consideration as a possible therapeutic agent for
preventing bone loss during periodontitis.
In conclusion, this study revealed for the first time the
complex role of cysteine proteases from P. gingivalis in IL-
6 expression and Th17 differentiation. Active gingipains are
modulators of immune responses significantly affecting the
production of pro-inflammatory cytokines induced by other P.
gingivalis virulence factors. On the other hand, the differentiation
of naive CD4+ cells into the Th17 subpopulation is strongly
enhanced by inactivation of gingipains, and promotes the
development of the T lymphocyte phenotype typical of bone
pathology. Taken together we propose that selective targeting
of the IL-6 signaling pathway, rather than gingipain inhibition,
might have a potential therapeutic value in treatment of
periodontitis.
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levels, which were arbitrarily set at 1. Data are presented as mean ± standard
deviation of assays performed three times, and were analyzed with a Student’s
t-test (#P < 0.05, ##P < 0.01 vs. control, ∗P < 0.05, ∗∗P < 0.01 to P. gingivalis
treated cells).
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